MENU

AARD Aardvark Therapeutics Inc Forecast, Technical & Fundamental Analysis

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

AARD is expected to report earnings to rise 4.55% to -68 cents per share on November 12

Aardvark Therapeutics Inc AARD Stock Earnings Reports
Q3'26
Est.
$-0.69
Q2'26
Beat
by $0.21
Q1'26
Missed
by $0.22
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.02
The last earnings report on August 11 showed earnings per share of -66 cents, beating the estimate of -87 cents. With 248.99K shares outstanding, the current market capitalization sits at 25.61M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLOO3.100.08
+2.65%
Gloo Holdings Inc.
JCI144.613.49
+2.47%
Johnson Controls International plc
AMTB30.300.07
+0.23%
Amerant Bancorp
CACC513.78-1.60
-0.31%
Credit Acceptance Corp
HOLO1.21-0.03
-2.42%
MicroCloud Hologram Inc

AARD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AARD has been loosely correlated with MGNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AARD jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AARD
1D Price
Change %
AARD100%
+1.48%
MGNX - AARD
38%
Loosely correlated
+3.42%
NAMS - AARD
32%
Poorly correlated
+0.95%
PHAT - AARD
32%
Poorly correlated
+2.16%
FDMT - AARD
29%
Poorly correlated
-0.16%
CADL - AARD
29%
Poorly correlated
-1.48%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
4370 La Jolla Village Drive
Phone
+1 858 225-7696
Employees
40
Web
https://www.aardvarktherapeutics.com
Aardvark Therapeutics (AARD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com